BioNovix News

BioNovix Confirms Management Team

Earthtimes | 2/26/2008

Background

In its first year, BioNovix produced exponential growth with revenues, while awaiting profitability on the horizon. In just one year, the Company has approximately 9,000 distributors and has expanded with a foot into Mexico, the Philippines and Korea, each at different stages of progress. In order to better serve its Independent Business Consultants and Investors, BioNovix, Inc. announces the following information.

BioNovix Management Team Confirmed

Marketwire | 2/25/2008

SCOTTSDALE, AZ--(Marketwire - February 25, 2008) - BioNovix, Inc., a Delaware corporation, announced confirmation of the revised Management structure, establishment of a new communications policy, including commencement of formal press releases, and ongoing brokerage discussions.

Management Team

Mark Labertew is Chief Executive Officer and Chief Financial Officer. Mark brings to BioNovix a background of profitable leadership in dynamic domestic and international enterprises. Mark has lead profitable companies, spanning diverse industries, from start-up through growth into multi-million dollar businesses, and has structured, negotiated and consummated high dollar corporate transactions and financings...

Eric Kuhrts now serves as a Director and Chief Science Officer. As co-founder of BioNovix and inventor of the products, Eric will bring renewed energy to his expanded role focusing on the continued research and development of the Wellness Index Test, Meridium product line. Eric is the founder and CEO of five pharmaceutical companies, and is the inventor of over 30 issued and pending patent applications. He has been involved in numerous aspects of management and research related to pharmaceuticals, diagnostics, and consumer products for over 18 years. One of his inventions, the Bios® Life2 generated over $180 million in annual revenues (close to $2 billion in sales over a 10 year period) for the Rexall Sundown company's Rexall Showcase International network marketing division. Eric has developed and licensed novel proprietary diagnostic biomarkers, major sports supplement products, numerous over-the counter (OTC) drug products, drug delivery systems, and many new biopharmaceutical formulations in the cardiovascular, and anti-inflammatory area. Eric also has extensive experience in the development of new drugs that require FDA approval via new drug application (IND/NDA) submissions. Eric is a graduate of the University of California at San Diego. Eric will continue to be a member of the company's Board of Directors. The Board is considering options on the position of Chairperson, who could possibly be any Director, officer or outside person.

Fred Auzenne now serves as a Director working with the Company primarily focused on international pursuits. As co-founder and primary visionary for the launch of BioNovix, Fred has been an extremely valued asset to the growth of the company. Fred spent seven years in U.S. Army Intelligence followed by a successful 15-year career in sales and marketing within the casino, pharmaceutical (Merck) and medical device (Medtronic) industries...

For the complete press release, please click the link below: